InnoCare Pharma Limited (HKG:9969)
Hong Kong
· Delayed Price · Currency is HKD 10.52
+0.16 (1.54%)
Apr 24, 2025, 4:08 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 21.33 billion as of April 24, 2025. Its market cap has increased by 118.53% in one year.
Market Cap
21.33B
Enterprise Value
15.58B
Revenue
1.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
10.52
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 21.33B, an increase of 73.73%. That is a compound annual growth rate of 11.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 21.33B | 68.85% |
| Dec 31, 2024 | 12.63B | -7.63% |
| Dec 29, 2023 | 13.68B | -44.57% |
| Dec 30, 2022 | 24.68B | 7.55% |
| Dec 31, 2021 | 22.95B | 32.04% |
| Dec 31, 2020 | 17.38B | 41.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 211.76B |
| Hansoh Pharmaceutical Group Company | 140.94B |
| JD Health International | 115.75B |
| WuXi Biologics | 91.89B |
| Innovent Biologics | 84.80B |
| Akeso | 83.38B |
| Alibaba Health Information Technology | 76.23B |
| CSPC Pharmaceutical Group | 70.59B |